WXXWY (WXXWY) Stock Price & Analysis
WXXWY (WXXWY) fell 2.31% to USD 7.6 as of June 9, 2026 at 23:57 UTC, according to Nexqual real-time market data.
WXXWY last closed at USD 7.78; the session ranged USD 7.55–7.7 on volume of 6,937 shares. Market capitalization is $15.67B, with a 52-week range of USD 6.02–11.21 (PNK). Source: Nexqual, June 9, 2026 at 23:57 UTC.
Key Statistics (as of June 9, 2026 at 23:57 UTC)
| Price | USD 7.6 |
|---|---|
| Change | ▼ 2.31% (down) |
| Previous Close | USD 7.78 |
| Open | USD 7.7 |
| Day Range | USD 7.55 – 7.7 |
| 52-Week Range | USD 6.02 – 11.21 |
| Volume | 6,937 shares |
| Market Cap | $15.67B |
| Exchange | PNK |
Technical Analysis (WXXWY)
Nexqual's technical model rates WXXWY "SELL" based on 2 bullish and 5 bearish signals across 124 daily candles, as of June 9, 2026 at 23:57 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 33.46 (neutral) |
| vs SMA50 | Below (USD 8.64) |
| MACD | -0.17 (negative) |
Analyst Ratings (WXXWY)
Wall Street analysts rate WXXWY "None", per Nexqual as of June 9, 2026 at 23:57 UTC.
| Consensus Rating | None |
|---|
Earnings (WXXWY)
Source: Nexqual, June 9, 2026 at 23:57 UTC.
Financials & Fundamentals (WXXWY)
| Total Revenue | $21.79B |
|---|---|
| Revenue Growth (YoY) | +17.20% |
| Gross Margin | +45.98% |
| Operating Margin | +33.14% |
| Profit Margin | +22.53% |
| ROE | +11.64% |
| Debt / Equity | 5.85 |
| Current Ratio | 3.39 |
| Total Cash | $15.73B |
| Total Debt | $3.10B |
| Free Cash Flow | $4.28B |
Source: Nexqual, June 9, 2026 at 23:57 UTC.
Financial Health Score (WXXWY)
Nexqual rates WXXWY's overall financial health "Solid" across five dimensions, as of June 9, 2026 at 23:57 UTC.
| Growth | Strong — Revenue +17% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 46%, operating 33% |
| Balance Sheet | Strong — $15.7B cash vs $3.10B debt, net cash position |
| Cash Flow | Strong — FCF $4.28B, 20% margin |
| Efficiency | Mixed — ROE 12%, ROA 6.9% |
Ownership (WXXWY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 2.06B |
| Float | 1.87B |
Source: Nexqual, June 9, 2026 at 23:57 UTC.
Leadership (WXXWY)
WXXWY is led by Zhisheng Chen (age 52), CEO & Executive Director, per Nexqual as of June 9, 2026 at 23:57 UTC.
| CEO & Executive Director | Zhisheng Chen (age 52) |
|---|---|
| Founder & Chairman | Ge Li (age 58) |
| CTO, Executive VP of Global Biologics Development Department & Executive Director | Xuejun Gu (age 54) |
| CFO & Executive VP | Ming Tu (age 56) |
| COO & Senior VP | Lihua Yu |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| WXIBF | Wuxi Biologics (Cayman) Inc | USD 4.4 | ▲ 0% |
| MKKGY | Merck KGaA | USD 32 | ▲ 2.11% |
| MPNGY | MEITUAN | USD 19.5 | ▼ 1.96% |
| UCBJY | UCB S.A. | USD 151.74 | ▲ 1.47% |
| SAUHY | Straumann Holding AG | USD 11.95 | ▲ 2.4% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 9, 2026 at 23:57 UTC. This page is informational and not investment advice.